Transparency Market Research

Global Research on Male Cancer Market - Industry, Trends and Forecast 2020

Transparency Market Research ( includes new market research report "Male Cancer Market" to its huge collection of research reports.


Albany, NY -- (SBWIRE) -- 11/06/2014 -- Cancer, according to the WHO resulted in the death of around 8.2 million individuals worldwide in 2012. Around 14% of the world’s total annual deaths are as a result of various cancers. Modern medicine has extended the life expectancy of a cancer patient by a great margin. However newer cases are diagnosed every year globally, there is at present 14 million newly diagnosed individuals annually, according to the WHO. This is commonly as a result of the changing lifestyles, unhealthy diet, hereditary factors and exposure to carcinogenic elements. Nearly half of the general cancer cases that include: colorectal cancer, lymphoma, carcinoma, and lung cancer; are presented by men. This also includes breast cancer cases, where around 1% of the cases are exhibited by males worldwide. Male specific cancers include: prostate cancer, testicular cancer, and penile cancer.

Early buyers will receive 10% customization on reports

Among these, according to the WHO, the most common cause of death in men is prostate cancer. Male specific cancers are generally benign/malignant tumors that rarely undergo metastasis. A majority of disease complications are due to metastasis of cancers that result in complete peripheral organ damage. Prostate cancer was also found by the International Journal of Cancer, to be the major cause of death among autopsies of natural death cases in geriatric males. Genetic factors accounts as a doubled risk factor among above 45 age males. Diagnosis of prostate cancer is first undergone by physical examination; it is then confirmed by MRI or a tissue biopsy.

Treatment is surgery in case of primary stages. In case of advanced disease, radiation, chemotherapy and therapeutic drugs are prescribed to a patient. The survival rate for prostate cancer is at 99% in the US. Testicular cancer on the other hand has a far lesser prevalence, but unlike prostate cancer it is reported in a younger male population i.e. 20-39 years, according to the US journal: Seminars in Oncology. In the UK and U.S combined, nearly 10000 individuals are diagnosed annually with testicular cancer. However a majority of these cases are benign tumors and are therefore the most successfully cured form of cancer in humans with a high survival rate.

Surgery involving the castration of testis (inguinal orchiectomy) is usually necessary to prevent malignancy, it also forms as a safe mode of diagnostic confirmation as biopsies have been found to increase the proliferation of testicular cancer. The procedure itself is generally without any complications and cures a majority of cancer patients worldwide. However testicular cancer is highly specific to Caucasian populations and is extremely rare among Asian and African decent populations. Penile cancers are even rarer form of cancer, but unlike prostate and testicular cancer, they are commonly as a result of human papiloma virus (HPV) infection. Hence penile cancer rates are high in developing countries. Chemotherapy, antiviral therapy and surgical excision are the common mode of treatment for penile cancer.

That said, the market for male cancer therapeutics is highly fragmented hence not easily quantifiable, however the surgery and overall treatment market remains in billions of USD, with new diagnostic screening procedures and drug combinations being patented every year, each having their own market segment. They are at present one of the most sought after investment segment in the healthcare drugs industry. With entry of Asian players the prices too are bound to decrease, thereby potentially increasing the overall therapeutics market. In developing markets of Asia and South America, their poor standards along with their population size make for a large market, however unavailability of affordable diagnostic procedures and therapeutic drugs is thought to be the major reason why diagnosis is few in number and why the markets haven’t been proliferated as of yet. The rest of the world region is also bound to follow a similar pattern with increased awareness and diagnostic rates, the number of diagnosed individuals undergoing therapy in this region is however very small.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends.

Geographies analyzed under this research report include:

- North America
- Asia Pacific
- Europe
- Rest of the World

This report provides comprehensive analysis of:

- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Reports on Pharmaceutical Market:

About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Inquiry Before Buying

Latest Upcoming Reports

Contact Us:
Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.

Tel: 518-618-1030

Browse market research blog: